Loading...
Cryo-Cell International Inc (CCEL) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of significant trading trends, no recent positive news, weak financial performance, and absence of proprietary trading signals suggest that this stock does not present a compelling opportunity for immediate investment. Holding off for better opportunities or further data would be prudent.
The MACD is positive and expanding, indicating a mild bullish momentum. RSI is neutral at 58.518, suggesting no overbought or oversold conditions. Moving averages are converging, which does not indicate a clear trend. Key support and resistance levels are Pivot: 3.358, R1: 3.464, S1: 3.252, R2: 3.529, S2: 3.187. Overall, the technical indicators are neutral to slightly bullish but not strong enough to warrant a buy.
Gross margin increased by 4.75% YoY in the latest quarter, which is a positive indicator for operational efficiency.
No significant trading trends from hedge funds or insiders. No recent news or event-driven catalysts. No recent congress trading data.
In Q3 2025, revenue dropped to $7,825,432 (-2.99% YoY), net income fell to $749,408 (-28.74% YoY), and EPS declined to 0.09 (-30.77% YoY). Gross margin improved to 74.61% (+4.75% YoY), but overall financial performance is weak.
No data available for analyst ratings or price target changes.